Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (17611)	3/18/1998 1:57:00 PM
From: Biotech Jim	Read Replies (1) of 32384

Genomics companies are starting to realize that there are sufficient targets to go after. It is the combichem approaches and medicinal chemists that are in high demand. Ask any company out there if they would like to offer a job to a good chemist. They would pay you a significant retainer if you could supply chemists. See also my previous comments on the MLNM thread related to pharmacogenomics. As to ISIP, they may market an antisense oligo for CMV retinitis, but when one realizes that its mechanism of action is different from that related to antisense inhibition, then one wonders whether antisense approaches will ever be realized. Ask any academic about their experiences with antisense. They will not be enthusiastic, and for reasons other than oligo stability. BJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next